CryoPort (NASDAQ:CYRX) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?

CryoPort, Inc. (NASDAQ:CYRX)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $10.07 and traded as high as $16.73. CryoPort shares last traded at $16.16, with a volume of 1,163,706 shares traded.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CYRX shares. Guggenheim raised their price objective on shares of CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Tuesday, May 5th. KeyCorp upped their target price on CryoPort from $15.00 to $17.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Craig Hallum increased their price target on CryoPort from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday. Weiss Ratings upgraded CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, BTIG Research upped their price objective on CryoPort from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, May 5th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $15.31.

CryoPort Trading Down 2.1%

The firm has a market capitalization of $814.50 million, a P/E ratio of 11.97 and a beta of 1.90. The business’s fifty day moving average is $11.60 and its 200 day moving average is $10.07.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Monday, May 4th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). The business had revenue of $47.80 million for the quarter, compared to the consensus estimate of $44.86 million. CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%. As a group, sell-side analysts predict that CryoPort, Inc. will post -0.85 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Jerrell Shelton sold 7,918 shares of CryoPort stock in a transaction on Monday, March 16th. The stock was sold at an average price of $8.00, for a total value of $63,344.00. Following the transaction, the chief executive officer directly owned 1,054,501 shares in the company, valued at $8,436,008. The trade was a 0.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mark W. Sawicki sold 3,235 shares of the business’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $8.00, for a total value of $25,880.00. Following the sale, the insider directly owned 103,697 shares in the company, valued at $829,576. This trade represents a 3.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 59,939 shares of company stock worth $471,183 in the last three months. 10.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On CryoPort

Several hedge funds have recently made changes to their positions in CYRX. Empire Financial Management Company LLC raised its stake in CryoPort by 24.4% during the 1st quarter. Empire Financial Management Company LLC now owns 502,575 shares of the company’s stock valued at $4,161,000 after purchasing an additional 98,714 shares during the period. Quantinno Capital Management LP boosted its position in shares of CryoPort by 30.7% in the first quarter. Quantinno Capital Management LP now owns 43,966 shares of the company’s stock worth $364,000 after buying an additional 10,337 shares during the period. Granahan Investment Management LLC boosted its position in shares of CryoPort by 475.0% in the first quarter. Granahan Investment Management LLC now owns 231,138 shares of the company’s stock worth $1,914,000 after buying an additional 190,938 shares during the period. Renaissance Technologies LLC grew its holdings in shares of CryoPort by 62.9% during the first quarter. Renaissance Technologies LLC now owns 368,110 shares of the company’s stock valued at $3,048,000 after buying an additional 142,070 shares in the last quarter. Finally, State of Wyoming grew its holdings in shares of CryoPort by 9.4% during the first quarter. State of Wyoming now owns 42,520 shares of the company’s stock valued at $352,000 after buying an additional 3,638 shares in the last quarter. Hedge funds and other institutional investors own 92.90% of the company’s stock.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.